Document Preview Unavailable

APOBEC3A drives acquired resistance to targeted therapies in non-small cell lung cancer

Isozaki, Hideko; Abbasi, Ammal; Nikpour, Naveed; Langenbucher, Adam; Su, Wenjia; et al.  bioRxiv, Jan 21, 2021.

You might have access to this document